157 related articles for article (PubMed ID: 14697789)
1. 8-Quinolinamines conjugated with amino acids are exhibiting potent blood-schizontocidal antimalarial activities.
Vangapandu S; Sachdeva S; Jain M; Singh S; Singh PP; Kaul CL; Jain R
Bioorg Med Chem; 2004 Jan; 12(1):239-47. PubMed ID: 14697789
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates.
Jain M; Vangapandu S; Sachdeva S; Jain R
Bioorg Med Chem; 2004 Mar; 12(5):1003-10. PubMed ID: 14980613
[TBL] [Abstract][Full Text] [Related]
3. 8-quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents.
Vangapandu S; Sachdeva S; Jain M; Singh S; Singh PP; Kaul CL; Jain R
Bioorg Med Chem; 2003 Oct; 11(21):4557-68. PubMed ID: 14527552
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB
Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538
[TBL] [Abstract][Full Text] [Related]
6. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.
Peters W; Robinson BL; Milhous WK
Ann Trop Med Parasitol; 1993 Dec; 87(6):547-52. PubMed ID: 8122915
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines.
Kaur K; Patel SR; Patil P; Jain M; Khan SI; Jacob MR; Tekwani BL; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):915-930. PubMed ID: 17084633
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of chiral chloroquine and its analogues as antimalarial agents.
Sinha M; Dola VR; Soni A; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
Bioorg Med Chem; 2014 Nov; 22(21):5950-60. PubMed ID: 25284252
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1992 Oct; 86(5):455-65. PubMed ID: 1288426
[TBL] [Abstract][Full Text] [Related]
10. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo.
Peters W; Robinson BL; Rossier JC; Misra D; Jefford CW; Rossiter JC
Ann Trop Med Parasitol; 1993 Feb; 87(1):9-16. PubMed ID: 8346994
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis of primaquine analogues and their antimalarial activity in mice].
Jiang Q; Zhong J; Shi Y; Li G
Yao Xue Xue Bao; 1998; 33(3):194-200. PubMed ID: 11938965
[TBL] [Abstract][Full Text] [Related]
12. Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo.
Tripathi R; Jefford CW; Dutta GP
Parasitology; 2006 Jul; 133(Pt 1):1-9. PubMed ID: 16764736
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
Biot C; Glorian G; Maciejewski LA; Brocard JS
J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies.
Ongarora DS; Strydom N; Wicht K; Njoroge M; Wiesner L; Egan TJ; Wittlin S; Jurva U; Masimirembwa CM; Chibale K
Bioorg Med Chem; 2015 Sep; 23(17):5419-32. PubMed ID: 26264839
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of blood schizontocidal activity of quinine and quinidine against drug resistant rodent malaria.
Kazim M; Puri SK; Dutta GP
J Commun Dis; 1991 Dec; 23(4):254-6. PubMed ID: 1842807
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, β-hematin inhibition studies and antimalarial evaluation of dehydroxy isotebuquine derivatives against Plasmodium berghei.
Romero AH; Acosta ME; Gamboa N; Charris JE; Salazar J; López SE
Bioorg Med Chem; 2015 Aug; 23(15):4755-4762. PubMed ID: 26081761
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of new antimalarial agents from 4-aminoquinoline.
Solomon VR; Puri SK; Srivastava K; Katti SB
Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868
[TBL] [Abstract][Full Text] [Related]
19. The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
Peters W; Stewart LB; Robinson BL
Ann Trop Med Parasitol; 2003 Apr; 97(3):221-36. PubMed ID: 12803854
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Ayush-64 for blood schizontocidal activity against rodent and simian malaria parasites.
Kazim M; Puri SK; Dutta GP; Narasimham MV
Indian J Malariol; 1991 Dec; 28(4):255-8. PubMed ID: 1824361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
